The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007.
The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007.
Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars.
Reasons to Purchase
- Gain insights into the industry, leading companies and competitors through a single report
- Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data
- Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies
- Determine industry attractiveness from five-forces analysis of constituent segments.
TABLE OF CONTENTS
Executive Summary 7
Industry analysis 7
Industry definition 7
Research highlights 7
Top 10 companies landscape 8
Market Value 9
Market Forecast 10
Market Segmentation--Product 11
Market Segmentation--Geographic 12
Five Forces Analysis 13
Buyer power 14
Supplier power 15
New entrants 16
Top 10 Companies Landscape 19
Revenue analysis 23
Copyright©2009 PR Newswire.
All rights reserved